Use of inflammatory markers to guide cancer treatment

Clin Pharmacol Ther. 2011 Sep;90(3):475-8. doi: 10.1038/clpt.2011.122. Epub 2011 Jul 20.

Authors

S J Clarke¹, W Chua, M Moore, S Kao, V Phan, C Tan, K Charles, D C McMillan

Affiliation

¹ Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia. stephen.clarke@sydney.edu.au

PMID: 21775983
DOI: 10.1038/clpt.2011.122

No abstract available

Publication types

Review

MeSH terms

Biomarkers / blood*
C-Reactive Protein / analysis*
Humans
Inflammation / physiopathology*
Neoplasms / blood
Neoplasms / drug therapy
Neoplasms / surgery
Neoplasms / therapy*
Prognosis

Substances

Biomarkers
C-Reactive Protein